NEU 0.72% $20.72 neuren pharmaceuticals limited

Acadia, page-478

  1. 270 Posts.
    lightbulb Created with Sketch. 57
    Acadia met lower end of expectations for daybue guidance. Didnt blow it out of the park but with stated seasonal factors are back to runrate it seems. So positive for the rest of the year, further confirmation that the culper report was a load of baloney.

    Seems slight miss on revenue for acadia but a beat on earnings. In this market a miss would result in a sell off but there is no froth in Acadia's shareprice so I tend to think there wont me much impact for its shareprice, business as usual. I note shareprice after hours is back to -1%.

    As for neuren, update solidifies ongoing performance for daybue with the upside to come within next 2 weeks. should be good buying over the next 2 weeks.

    Would be interested in the local analysts updates and the result against their expectations for those that have access.

 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$20.72
Change
-0.150(0.72%)
Mkt cap ! $2.648B
Open High Low Value Volume
$20.96 $21.28 $20.61 $4.984M 239.1K

Buyers (Bids)

No. Vol. Price($)
1 782 $20.61
 

Sellers (Offers)

Price($) Vol. No.
$20.72 1021 2
View Market Depth
Last trade - 16.10pm 24/07/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.